LAB

Standard BioToolsD

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

Quote time unavailable

View Chart

Current thesis

Composite grade D from latest DB weights. Momentum 35.8 / Value 56.9

Posture

Defensive

Lead driver

Value

What changed

Value remains the lead driver in the composite, 7D delta -0.0.

What can break

Mixed signals. Wait for cleaner trend confirmation.

Momentum

Value

Sentiment

N/A

Setup hits (3d)

0 · Net Neutral

AI TargetsBase - · Bull - · Bear -Analysis date unavailable; returns require an exact persisted reference.

Data freshness

Prices

Unavailable: Price unavailable

Fundamentals

As of 2026-08-17 • Vendor: Data Vendor v1

Scores

As of 2026-09-11 • Model: HYBRID_IC_RP

AI Memo

Unavailable: No memo yet

Investment thesis

As of 2026-09-11

Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-11. Definitions

Supporting evidence

What

Grade D · Defensive

Confidence Medium · Net Neutral

Target $1.35

Why

Momentum36 · Δ7d -

Value57 · Δ7d -0.0

SentimentN/A · Δ7d -

So what

Weak posture (Net Neutral). Prioritize risk control and patience.

Confirming evidence

• Value remains the lead driver in the composite, 7D delta -0.0.

Contradictions & invalidation

• Mixed signals. Wait for cleaner trend confirmation.

Catalyst clock

No dated catalyst is available.

Lead driver: Value · See fundamentals

Momentum

25% active weight

Current posture

7d trendTrend unavailable

Trend unavailable

Δ7d

Δ21d

Value

75% active weight

Current posture

7d trendFlat

Δ7d

-0.0

Δ21d

-0.3

Sentiment

N/A

Coverage pending

No current score

7d trendTrend unavailable

Trend unavailable

Δ7d

Δ21d

Why this grade

Composite grade D. Momentum 35.8 / Value 56.9

Fundamentals (TTM)

As of 2026-08-17

Market Cap

$268.72M

Beta

1.28

Shares Out

392.58M

P/E (TTM) · Derived

-3.5

P/S (TTM)

3.94

P/FCF (TTM) · Derived

-3.21

Rev YoY

-7.6%

EPS YoY

-22.1%

Gross Margin

+49.1%

Op Margin

-74.0%

Net Debt

-$156.75M

Current Ratio

9.10

As of 2026-09-11 • Updated nightlySource: Internal modelMethods & Data